Stocks / NASDAQ / Harpoon Therapeutics, Inc.

Harpoon Therapeutics, Inc.

Our Opinion

Harpoon Therapeutics, Inc. is on the Cruelty Free Investing use of animals list because they conduct pre-clinical studies of their drugs on animals to assess a product’s safety profile.

Supporting Evidence:

The company stated in the following report that they exploit animals for product testing.

“In 2018, we completed an IND-enabling, multi-dose GLP toxicology study in animals. HPN536, which has been observed to bind to cynomolgus monkey MSLN with comparable affinities as human MSLN, delivered clear histological evidence of target enhancement.” (Page 103) Read the full document

Company Description

Company Website: